Terfenadine prevents NMDA receptor-dependent and -independent toxicity following sodium channel activation

Brain Research

Volumn 842, Issue 2, 1999, Pages 478-481

  Díaz Trelles, Ramón ^a   Novelli, Antonello ^a   Puia, Giulia ^b   Fernández Sánchez, M Teresa ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Fac of Psychol Univ of Oviedo ^*

Author keywords

Excitotoxicity; Glutamate release; Terfenadine

Indexed keywords

ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM CHANNEL; TERFENADINE; VERATRIDINE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CEREBELLUM; DEPOLARIZATION; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DIZOCILPINE MALEATE; GLUTAMIC ACID; NEURONS; PYRILAMINE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SAXITOXIN; SODIUM CHANNELS; TERFENADINE; TETRODOTOXIN; VERATRIDINE;

EID: 0032826835     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01828-4     Document Type: Article

References (17)

1. Dargent B., Arsac C., Tricaud N., Couraud F. Activation of voltage dependent sodium channels in cultured cerebellar granule cells induces neurotoxicity that is not mediated by glutamate release. Neuroscience. 73:1996;209-216.
2. Fernández M.T., Zitko V., Gascón S., Novelli A. The marine toxin okadaic acid is a potent neurotoxin for cultured cerebellar neurons. Life Sci. 49:1991;PL157-PL162.
3. Fernández-Sánchez M.T., Novelli A. Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity. FEBS Lett. 335:1993;124-131.
4. Galdzicki Z., Lin F., Moran O., Novelli A., Puia G., Sciancalepore M. Development of voltage-dependent ionic currents in rat cerebellar granule cells grown in primary culture. Int. J. Neurosci. 56:1991;193-200.
5. Galdzicki Z., Coan E., Rapoport S.I. Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current. Brain Res. 604:1993;69-78.
6. Gallo V., Ciotti M.T., Aloisi F., Levi G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. U.S.A. 79:1982;7919-7923.
7. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., Schunack W., Levi R., Haas H.L. International union of pharmacology: XIII. Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
8. 2+ channel current in rat ventricular myocytes by terfenadine. Circ. Res. 81:1997;202-210.
9. McTavish D., Goa K.L., Ferrill M. Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy. Drugs. 39:1990;552-574.
10. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the NMDA receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
11. Novelli A., Torreblanca A., Losa-Uria P., Fernández-Sánchez M.T. Role of intracellular calcium in neuronal survival to excitatory aminoacid stimulation. Soc. Neurosci. Abstr. 21:1995;530.13.
12. Suessbrich H., Waldegger S., Lang F., Busch A.E. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett. 385:1996;77-80.
13. Terlau H., Heinemann S.H., Stühmer W., Pusch M., Conti F., Imoto K., Numa S. Mapping the site of block by tetrodotoxin and saxitoxin of sodium channel II. FEBS Lett. 293:1991;93-96.
14. Valenzuela C., Delpón E., Franqueza L., Gay P., Vicente J., Tamargo J. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels. Eur. J. Pharmacol. 326:1997;257-263.
15. Woosley R.L. Cardiac actions of antihistamines. Annu. Rev. Pharmacol. Toxicol. 36:1996;233-252.
16. Yang J.-M., Goldenberg S., Gottesman M.M., Hait W.N. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 54:1994;730-737.
17. Zhang M.Q., Caldirola P., Timmerman H. Calcium antagonism and structure-affinity relationships of terfenadine, a histamine H1 antagonist, and some related compounds. J. Pharm. Pharmacol. 45:1993;63-66.